ReviewCell death & disease2024

Metabolic gatekeepers: harnessing tumor-derived metabolites to optimize T cell-based immunotherapy efficacy in the tumor microenvironment.

Yucheng Zheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.